Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Gynecology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 62 articles:
HTML format



Single Articles


    August 2022
  1. MCDANIELS-DAVIDSON C, Feng CH, Martinez ME, Canchola AJ, et al
    Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
    Cancer. 2022 Aug 2. doi: 10.1002/cncr.34404.
    PubMed     Abstract available


    July 2022
  2. MOUKARZEL LA, Ferrando L, Stylianou A, Lobaugh S, et al
    Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer.
    Cancer. 2022 Jul 6. doi: 10.1002/cncr.34356.
    PubMed     Abstract available


    June 2022
  3. RAUH-HAIN JA, Zubizarreta J, Nitecki R, Melamed A, et al
    Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study.
    Cancer. 2022 Jun 29. doi: 10.1002/cncr.34371.
    PubMed     Abstract available


  4. MARTH C, Abreu MH, Andersen KK, Aro KM, et al
    Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).
    Cancer. 2022 Jun 17. doi: 10.1002/cncr.34350.
    PubMed     Abstract available


  5. JAMIESON A, Barroilhet LM, McAlpine JN
    Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
    Cancer. 2022 Jun 3. doi: 10.1002/cncr.34328.
    PubMed     Abstract available


  6. O'ROURKE K
    Cemiplimab shines for recurrent cervical cancer.
    Cancer. 2022;128:2050-2051.
    PubMed    


  7. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed     Abstract available


    May 2022
  8. NERO C, Pasciuto T, Cappuccio S, Corrado G, et al
    Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
    Cancer. 2022 May 26. doi: 10.1002/cncr.34331.
    PubMed     Abstract available


  9. STENZEL AE, Bustamante G, Sarkin CA, Harripersaud K, et al
    The intersection of sexual orientation with race and ethnicity in cervical cancer screening.
    Cancer. 2022 May 16. doi: 10.1002/cncr.34213.
    PubMed     Abstract available


  10. O'ROURKE K
    Pembrolizumab is effective for endometrial cancer.
    Cancer. 2022;128:1886-1887.
    PubMed    


    April 2022
  11. O'ROURKE K
    Better HPV vaccination and cervical cancer screening needed.
    Cancer. 2022;128:1559.
    PubMed    


    February 2022
  12. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed     Abstract available


  13. LU E, Hatchell KE, Nielsen SM, Esplin ED, et al
    Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.
    Cancer. 2022;128:675-684.
    PubMed     Abstract available


    January 2022
  14. HENDERSON TO, Fowler BW, Hamann HA, Nathan PC, et al
    Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Cancer. 2022;128:373-382.
    PubMed     Abstract available


  15. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    PubMed     Abstract available


    December 2021
  16. MCBRIDE CM, Pathak S, Johnson CE, Alberg AJ, et al
    Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.
    Cancer. 2021 Dec 9. doi: 10.1002/cncr.34053.
    PubMed     Abstract available


  17. BELLONE S, Roque DM, Siegel ER, Buza N, et al
    A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34025.
    PubMed     Abstract available


  18. ANTILL Y, Buchanan DD, Scott CL
    Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34024.
    PubMed     Abstract available


  19. MOMTAZ P, O'Connor CA, Chou JF, Capanu M, et al
    Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
    Cancer. 2021;127:4393-4402.
    PubMed     Abstract available


    November 2021
  20. PEI J, Li M, Wu C, Xu M, et al
    Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34029.
    PubMed    


  21. LIN S, Gao K, Jin M
    Reply to Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34031.
    PubMed    


  22. TEMKIN SM, Smeltzer MP, Dawkins MD, Boehmer LM, et al
    Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations.
    Cancer. 2021 Nov 17. doi: 10.1002/cncr.34023.
    PubMed     Abstract available


  23. DESAI S, Zhu MJ, Lapidos-Salaiz I
    Cervical cancer prevention: Human papillomavirus testing as primary screening.
    Cancer. 2021 Nov 12. doi: 10.1002/cncr.34006.
    PubMed     Abstract available


    October 2021
  24. DIN HN, Strong D, Singh-Carlson S, Corliss HL, et al
    Association between pregnancy intention and preconception health behaviors.
    Cancer. 2021 Oct 11. doi: 10.1002/cncr.33958.
    PubMed     Abstract available


  25. BRANDT HM, Kepka D, Kirchhoff AC, Daniel CL, et al
    Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33920.
    PubMed    


  26. NIERENGARTEN MB
    Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
    Cancer. 2021;127:3499.
    PubMed    


  27. NIERENGARTEN MB
    Rucaparib is a safe and effective maintenance therapy for advanced pancreatic cancer.
    Cancer. 2021;127:3498.
    PubMed    


  28. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed     Abstract available


    September 2021
  29. KOTSOPOULOS J, Kim SJ, Armel S, Bordeleau L, et al
    An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
    Cancer. 2021;127:3183-3193.
    PubMed     Abstract available


    August 2021
  30. LIN S, Gao K, Gu S, You L, et al
    Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years.
    Cancer. 2021 Aug 9. doi: 10.1002/cncr.33795.
    PubMed     Abstract available


  31. HUEPENBECKER SP, Sun CC, Fu S, Zhao H, et al
    Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
    Cancer. 2021 Aug 4. doi: 10.1002/cncr.33829.
    PubMed     Abstract available


  32. SCHAEFER IM, Lundberg MZ, Demicco EG, Przybyl J, et al
    Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
    Cancer. 2021;127:2666-2673.
    PubMed     Abstract available


    July 2021
  33. LEHRER S, Rheinstein PH
    FBXW7, L1CAM, and TGM2 in endometrial cancer.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33782.
    PubMed    


  34. URICK ME, Yu EJ, Bell DW
    Reply to FBXW7, L1CAM, and TGM2 in endometrial cancer.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33781.
    PubMed    


  35. LAMOTHE S, Ramia de Cap M
    Survival analysis and treatment effects in patients with endometrial cancer and POLE mutations.
    Cancer. 2021 Jul 27. doi: 10.1002/cncr.33806.
    PubMed    


  36. TALHOUK A, McAlpine JN
    Reply to Survival analysis and treatment effects in patients with endometrial cancer and POLE mutations.
    Cancer. 2021 Jul 27. doi: 10.1002/cncr.33808.
    PubMed    


  37. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    PubMed     Abstract available


  38. NYAKUDARIKA NC, Holschneider CH, Sinno AK
    Universal social needs assessment in gynecologic oncology: An important step toward more informed and targeted care in the public safety net.
    Cancer. 2021 Jul 12. doi: 10.1002/cncr.33761.
    PubMed     Abstract available


    June 2021
  39. MAKHNOON S, Tran G, Levin B, Mattie KD, et al
    Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33668.
    PubMed     Abstract available


  40. PRINTZ C
    Some patients with postmenopausal breast cancer can avoid adjuvant chemotherapy: Data indicate that some postmenopausal women with breast cancer can safely skip adjuvant chemotherapy.
    Cancer. 2021;127:1951-1952.
    PubMed    


    May 2021
  41. KIM SR, Tone A, Kim RH, Cesari M, et al
    Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
    Cancer. 2021 May 13. doi: 10.1002/cncr.33625.
    PubMed     Abstract available


  42. GARCIA-SOTO AE, McKenzie ND, Whicker ME, Pearson JM, et al
    Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Cancer. 2021 May 1. doi: 10.1002/cncr.33449.
    PubMed     Abstract available


    April 2021
  43. BUTLER SS, Mahal BA, Moslehi JJ, Nohria A, et al
    Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
    Cancer. 2021 Apr 27. doi: 10.1002/cncr.33486.
    PubMed     Abstract available


  44. CHEN YS, Zhou ZN, Glynn SM, Frey MK, et al
    Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the coronavirus disease 2019 (COVID-19) pandemic among low-income women in New York City.
    Cancer. 2021 Apr 26. doi: 10.1002/cncr.33537.
    PubMed     Abstract available


  45. URICK ME, Yu EJ, Bell DW
    High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
    Cancer. 2021 Apr 19. doi: 10.1002/cncr.33567.
    PubMed     Abstract available


  46. PRINTZ C
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.
    PubMed    


  47. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    PubMed     Abstract available


  48. MCALPINE JN, Chiu DS, Nout RA, Church DN, et al
    Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33516.
    PubMed     Abstract available


    March 2021
  49. LEE CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al
    Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33517.
    PubMed     Abstract available


  50. RODRIGUEZ VE, LeBron AMW, Chang J, Bristow RE, et al
    Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
    Cancer. 2021 Mar 15. doi: 10.1002/cncr.33502.
    PubMed     Abstract available


  51. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available


    February 2021
  52. MULLINS MA, Ruterbusch JJ, Clarke P, Uppal S, et al
    Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33488.
    PubMed     Abstract available


  53. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    PubMed     Abstract available


  54. SIMON MS, Hastert TA, Barac A, Banack HR, et al
    Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
    Cancer. 2021;127:598-608.
    PubMed     Abstract available


    January 2021
  55. SELLA T, Partridge AH
    A new look at old problems: Ovarian function suppression in the real world.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33368.
    PubMed    


  56. REEDER-HAYES KE, Mayer SE, Lund JL
    Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33367.
    PubMed     Abstract available


  57. MELIN JM, Seppanen VI, Ylostalo TM, Malila NK, et al
    Risk of induced abortions in childhood cancer survivors.
    Cancer. 2021 Jan 25. doi: 10.1002/cncr.33384.
    PubMed     Abstract available


  58. YUAN Y, Pan K, Mortimer J, Chlebowski RT, et al
    Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Cancer. 2021 Jan 21. doi: 10.1002/cncr.33407.
    PubMed     Abstract available


    December 2020
  59. LARA OD, Smith MJ, Wang Y, O'Cearbhaill R, et al
    Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy.
    Cancer. 2020 Dec 9. doi: 10.1002/cncr.33335.
    PubMed     Abstract available


  60. PRINTZ C
    Screening entire populations for breast and ovarian cancer could prevent millions of cases worldwide, study says.
    Cancer. 2020;126:5007.
    PubMed    


  61. POORVU PD, Gelber SI, Zheng Y, Ruddy KJ, et al
    Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33342.
    PubMed     Abstract available


    April 2020
  62. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: